The company reported ($2.80) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.95) by ($0.85), FiscalAI reports. NextCure Stock Up 4.5%NASDAQ:NXTC traded up $0.25 during trading hours on Friday, hitting $5.84. In the last three months, insiders bought 346,761 shares of company stock worth $1,710,807. Wall Street Zen downgraded NextCure from a “hold” rating to a “sell” rating in a report on Saturday, July 18th. Zacks Research raised shares of NextCure from a “strong sell” rating to a “hold” rating in a research report on Thursday, June 11th.